You have 9 free searches left this month | for more free features.

childhood malignant testicular germ cell tumor

Showing 9951 - 9975 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Peripheral Blood Proteomics to Predict Treatment Response and

Recruiting
  • Non Small Cell Lung Cancer
  • Blood draw
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
May 10, 2022

Hepatocellular Carcinoma, Transarterial Chemoembolization Trial in Guangzhou (TACE-HAIC plus lenvatinib)

Recruiting
  • Hepatocellular Carcinoma
  • Transarterial Chemoembolization
  • TACE-HAIC plus lenvatinib
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Sep 20, 2021

Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent DLBCL Trial in Seattle (biological,

Recruiting
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +20 more
  • Chimeric Antigen Receptor T-Cell Therapy
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 11, 2022

Immune System, Nutrition, Inflammation Trial in Davis (High saturated fat challenge meal, High mono unsaturated fat challenge

Not yet recruiting
  • Immune System
  • +2 more
  • High saturated fat challenge meal
  • High mono unsaturated fat challenge meal
  • Davis, California
    USDA Western Human Nutrition Research Center
Mar 29, 2023

Basal Cell Carcinoma Trial in Baltimore (Nivolumab, Ipilimumab, Relatlimab)

Recruiting
  • Basal Cell Carcinoma
  • Baltimore, Maryland
    Johns Hopkins Hospital
Mar 10, 2022

Prostate Cancer Trial in Saint-Herblain (prostate biopsies)

Recruiting
  • Prostate Cancer
  • prostate biopsies
  • Saint-Herblain, France
    ICO
Apr 21, 2022

Circulating Tumor DNA From LIquid Biopsy in Early Stage NSCLC

Terminated
  • Non Small Cell Lung Cancer
  • biospecimen collection
  • Atlanta, Georgia
  • +5 more
Nov 18, 2020

Effect of Sedation on Heart Rate Variability Trial in Istanbul (Precedex 200 MCG in 2 ML Injection, DORMICUM 5MG/5 ML)

Active, not recruiting
  • Effect of Sedation on Heart Rate Variability
  • Precedex 200 MCG in 2 ML Injection
  • DORMICUM 5MG/5 ML
  • Istanbul, Turkey
    Mustafa Emre Gurcu
May 7, 2021

Real-world Data of Afatinib Treatment in First-line Setting and

Active, not recruiting
  • Non-squamous, Non-Small Cell Lung Cancer
  • Tokyo, Japan
    Nippon Boehringer Ingelheim Co., Ltd.
Jan 9, 2023

Esophageal Cancer Trial in Warsaw (Cytosponge cell collection device)

Recruiting
  • Esophageal Cancer
  • Cytosponge cell collection device
  • Warsaw, Poland
    Medical Centre for Postgraduate Education
Sep 4, 2021

Multiple Sclerosis, Clinically Isolated Syndrome Trial in Worldwide (Ocrelizumab)

Recruiting
  • Multiple Sclerosis
  • Clinically Isolated Syndrome
  • San Francisco, California
  • +5 more
Aug 2, 2022

Renal Cell Carcinoma, Ovarian Tumor Trial in Japan, United States (DS-6000a)

Recruiting
  • Renal Cell Carcinoma
  • Ovarian Tumor
  • Lake Mary, Florida
  • +6 more
Aug 2, 2022

A Study of Nivolumab in Patients With Head and Neck Cancer.

Active, not recruiting
  • Squamous Cell Carcinoma of the Head and Neck; Head and Neck Cancer; Head and Neck Carcinoma; Cancer of the Head and Neck
  • Nivolumab
  • Paris Cedex 5, France
    Local Institution
Mar 23, 2022

Pancreatic Cancer Trial in Chicago (Lidocaine Hydrochloride, Saline Solution for Injection)

Recruiting
  • Pancreatic Cancer
  • Lidocaine Hydrochloride
  • Saline Solution for Injection
  • Chicago, Illinois
    University of Illnois at Chicago
Apr 8, 2022

Gastro-enteropancreatic Neuroendocrine Tumor Trial (Pasireotide, Diazoxide)

Withdrawn
  • Gastro-enteropancreatic Neuroendocrine Tumor
  • (no location specified)
Feb 17, 2022

Solid Tumor Trial in Hangzhou (MAX-10181)

Recruiting
  • Solid Tumor
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, Zhejiang University
Jan 18, 2022

Liver Cancer Trial in Luzhou (FluoAB)

Recruiting
  • Liver Cancer
  • Luzhou, Sichuan, China
    The Affiliated Hospital of Southwest Medical University
May 26, 2022

Extracellular Vesicles and Particles as Biomarkers of Recurrence

Recruiting
  • Non-Small Cell Lung Cancer
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jun 16, 2022

    Lymphocytic Leukemia, Chronic, DLBCL Trial in Australia, United States (GDC-0853)

    Completed
    • Lymphocytic Leukemia, Chronic, Diffuse Large B-Cell Lymphoma
    • Stanford, California
    • +9 more
    Jun 16, 2022

    Women With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2 Trial in Stockholm (Mifepristone)

    Completed
    • Women With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2
    • Stockholm, Sweden
      Department of Woman and Child Health Karolinska University Hospi
    Jan 15, 2022

    Spinal Cord Injuries Trial in Chicago (Acute Intermittent Hypoxia)

    Completed
    • Spinal Cord Injuries
    • Acute Intermittent Hypoxia
    • Chicago, Illinois
      Shirley Ryan AbilityLab
    Aug 22, 2022

    Advanced Solid Tumor, DLBCL Trial in United States (RNK05047)

    Recruiting
    • Advanced Solid Tumor
    • DLBCL
    • Atlanta, Georgia
    • +3 more
    Aug 23, 2022

    NSCLC, NSCLC, Nonsmall Cell Lung Cancer Trial in Saint Louis (Nintedanib)

    Active, not recruiting
    • Carcinoma, Non-Small-Cell Lung
    • +2 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jan 3, 2023

    Sarcoma, Ewing, Tumor Metastasis Trial in Worldwide (Abemaciclib, Irinotecan, Temozolomide)

    Not yet recruiting
    • Sarcoma, Ewing
    • Neoplasm Metastasis
    • Phoenix, Arizona
    • +29 more
    Aug 17, 2022